Maksimov,S.L., Yushchuk,N.D., Roslyi,I.M., Kravchenko,A.V., Danilova,T.V.

Experience of using Neovir for the treatment of acute viral hepatitis C

State Medical Stomatology University, State Clinical Infectious Hospital No. 2, Central Research Institute of Epidemiology, Moscow, Russia

Neovir, an inductor of interferon-a, was injected intramuscularly to 15 male patients aged 16 — 44 years with diagnosed acute viral hepatitis in a dose of 250 mg a day, 2 — 3 times a week, for 3 months. By the end of the therapy hepatitis C virus RNA could still be isolated in 84.6% of the patients; the values of AlaT, AsaT and alkaline phosphatase exceeded the normal levels twofold. The result of the therapy is regarded as ineffective.
Zh. Mikrobiol. (Moscow), 2003, P. 64—67